Currently predicting for Thu, 4 Jun 2026

INVA Prediction Chart

INVA Predictions History

Latest community submissions for INVA.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Jul 3, 2024 $16.43 -0.42% $16.33 V 99.39% 4
Jul 3, 2024 $16.37 -0.81% $16.33 V 99.78% 6
Jul 3, 2024 $16.42 -0.50% $16.33 V 99.47% 4
JS JS Pro
Jul 22, 2021 $13.53 +0.89% $13.41 X 99.11% 2
Jul 22, 2021 Bullish $13.41 X 0
May 2, 2019 $13.74 -8.03% $14.94 X 91.97% 0
Apr 22, 2019 $13.03 -2.98% $13.43 X 97.02% 0
JS JS Pro
Nov 26, 2018 $17.74 +2.72% $17.27 X 97.30% 0
Jan 2, 2018 $14.19 -1.66% $14.43 X 98.30% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for INVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT INNOVIVA, INC
Innoviva
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE